Sales & Marketing

The program is aimed at raising funds for children with cancer and blood disorders.

The campaign is based on a messaging promoting an embrace of aging.

As the digital medium poses new threats to brand equity and public safety for pharma, what can drugmakers do to better balance its essential communications benefits with the risks?

The digital revolution has brought more efficient ways to reach and touch HCPs.

Webinar Date/Time: Thursday, October 3, 2024 at 2pm EDT|11am PDT|7pm BST|8pm CEST

The company partnered with Marius Pharmaceuticals to offer access to Kyzatrex.

The “Do It For You & Them” campaign focuses on the impact that virus has on day-to-day lives.

Strategies that can help maintain and grow your market share. Plus how to adapt to new competitive pressures and evolving customer needs.

According to the company, about one-third of the country is at risk for micronutrient deficiency.

The app provides users with lifestyle tips and plans based on the lifestyles of people living in regions with the highest lifespans.

In an interview with Pharm Exec Associate Editor Don Tracy, Carlos Doti, VP, head of medical affairs, US oncology business unit, offers his thoughts on the evolution of Lynparza across indications such as breast, prostate, and pancreatic cancers.

As HCPs continue to face time constraints and information overload, delivering relevant and personalized content becomes increasingly critical.

The partnership will allow both group to expand their operations and provide more solutions to underserved communities.

By embracing technology and integrating it seamlessly into your brand narrative, you can create a more engaging, personalized, and effective experience for HCPs.

Webinar Date/Time: Wed, Aug 28, 2024 11:00 AM EDT

Point of care messaging offers unique advantages in pharmaceutical marketing and should be a high priority in brand strategy discussions.

David Minkin, President & GM at epocrates, offers his insights into the importance of trust, first-party data, and strategic partnerships in ensuring successful marketing campaigns.

A study detailing how patients struggling with obesity interact with the life sciences industry suggests that they don’t get weight loss information from their doctors.

What pharma needs to do to keep up with the rise in value-based care.

Inizio’s chief operations officer discusses how pharmaceutical companies are tailoring their product launch strategies to meet the diverse needs of stakeholders.

Industry experts, in a roundtable discussion, explore the evolution of brand engagement in the age of AI, including the growing importance of message relevance—and, for pharma, going where the information is.

Respondents said they were concerned about their own mental health or the mental health of another person at higher rates since 2022.

The industry must find a way to balance consumer privacy and a return on investment in pharma marketing.

Blankenship, vice president of policy initiatives and advocacy at The Academy of Nutrition and Dietetics, discusses how AOMs can play a role in creating strategies to manage the obesity epidemic.

In this Pharmaceutical Executive video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One, discusses what other tactics healthcare marketers can utilize to connect with diverse audiences on a deeper level

In this Pharmaceutical Executive video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but address their specific healthcare needs

Greater Than One’s Chief Strategy Officer, Andrew Bast, shares his takeaways from 2024 Rare Disease Summit in Philadelphia, PA.

Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.

In an interview with Pharm Exec Associate Editor Don Tracy, Fady Boctor, President, Chief Commercial Officer, Petros Pharmaceuticals provides his thoughts on what the future looks like when it comes to over-the-counter (OTC) contraceptives.